84-4369-11 ARHGAP39, CT (CrGAP, Vilse, Rho GTPase-Activating Protein 39) 100ug 352119
特徴
- Rho GTPases are important regulators of the actin cytoskeleton and consequently influence the shape and migration of cells.
- GTPase-activating proteins (GAPs) accelerate the intrinsic rate of GTP hydrolysis of Ras-related proteins.
- ARHGAP39 (Rho GTPase activating protein 39) is a 1083aa nuclear protein that contains one MyTH4 domain, one Rho GAP domain and two WW domains.
- It is encoded by a gene located on human chromosome 8, which is associated with a variety of diseases and malignancies.
- ARHGAP39 regulates robo signaling and plays important roles in axon guidance.
- Applications:Suitable for use in ELISA and Western Blot.
- Other applications not tested.
- Recommended Dilution:Western Blot: 1-2ug/mlOptimal dilutions to be determined by the researcher.
- Positive Control:A-20 Cell Lysate
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size：100ug
- Host：rabbit
- Source Antibody：human
- Grade：Affinity Purified
- Purity：Purified by immunoaffinity chromatography.
- Form：Supplied as a liquid in PBS, 0.02% sodium azide.
- Specificity：Recognizes human ARHGAP39. Species Crossreactivity: mouse and rat
- Isotype：IgG
- Calc Applications Abbrev：E WB
- Calc Crossreactivity：Hu Mo Rt
- Immunogen：Synthetic peptide corresponding to 18aa from human ARHGAP39 at C-terminal.
- Shelf Life：6months
- EU Commodity Code：30021010
- この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL：06-6447-8641
- FAX：06-6447-8642
- E-mail：[email protected]
